Newsroom > In the News
In the news
News headlines are articles that reference ResMed's company, people, or business practices.
May 22, 2017PCHAlliance
The Personal Connected Health Alliance (PCHAlliance) today announced the addition of twelve new member companies during the first quarter of 2017, including five at the Global level -- AT&T, Eli Lilly and Company, IPSOS Healthcare, ResMed and Samsung. As a Global Member, each had the opportunity to nominate an executive to the PCHAlliance Board of Managers and all have been accepted.
May 21, 2017MedPage Today
Patients with persistent hypercapnia following an acute exacerbation of chronic obstructive pulmonary disease (COPD) had a longer time to death or rehospitalization if non-interventional ventilation was added to their home oxygen therapy, researchers found.
For Patients With Treatment-emergent Central Sleep Apnea, Switching from CPAP to ASV Significantly Improves ComplianceMay 16, 2017Sleep Review
ResMed Inc announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA.
May 8, 2017Becker's Hospital Review
Amy Cook, Director of Healthcare Informatics at ResMed, was named to Becker's list of 110 Women in Medtech to Know in 2017. Joining ResMed in 2012, she was integral in developing and rolling out the company's suite of connected health IT services and platforms.
S+, Setting a New Standard in Consumer and Clinical Sleep Technology: Interview with Colin Lawlor, CEO of SleepScore LabsMay 3, 2017Medgadget
The S+ platform is the newest technology disrupting the $60B consumer sleep industry. Developed by SleepScore Labs, a joint venture between ResMed, a 25-year leader in prescription sleep medical devices, Dr. Mehmet Oz, and Pegasus Capital Advisors, the S+ is a clinical grade, non-prescription, non-contact sleep monitoring device coupled with a mobile app.
April 25, 2017San Diego Union-Tribune
Instead of packing up their larger, bedside machines from home for a trip, sleep apnea patients can travel with a much smaller device, according to the company. It’s akin to taking a tablet on the road while leaving the desktop computer at home, said ResMed Chief Executive Michael “Mick” Farrell.
April 25, 2017Xconomy
The debut of ResMed’s AirMini is only part of a bigger picture, according to Jim Hollingshead, ResMed’s president of the Americas. Hollingshead said the AirMini is part of a strategic shift that began four or five years ago, when ResMed began to pivot from developing medtech hardware to becoming a provider of “connected healthcare.”
April 13, 2017HME Business
Individuals with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant with their therapy after switching from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to a broad survey of sleep patients patients with treatment-emergent CSA that was commissioned by sleep equipment maker ResMed.
April 10, 2017FeibusTech
Mike Feibus tries S+, the world's first non-contact sleep tracker, discusses what it does, what it has, and more.
April 4, 2017American Thoracic Society
The American Thoracic Society today announced a new $100,000 two-year research fellowship funded by ResMed in the area of noninvasive ventilation (NIV) in chronic obstructive pulmonary disease (COPD).